KalVista Pharmaceuticals, Inc.
KALV
$27.00
$0.010.04%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 07/31/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 36.82% | 12.20% | -40.59% | -13.17% | -11.17% |
| Total Depreciation and Amortization | 69.53% | 62.13% | 12.62% | -13.58% | -13.73% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 203.02% | 39.69% | 30.90% | 7.23% | -30.37% |
| Change in Net Operating Assets | -565.78% | -181.76% | -82.63% | -86.51% | -69.06% |
| Cash from Operations | 59.78% | 23.61% | -9.97% | -69.77% | -79.43% |
| Capital Expenditure | -232.88% | -2,025.83% | -994.55% | -956.14% | -692.86% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -29.93% | 133.54% | 127.87% | 139.73% | 149.95% |
| Cash from Investing | -68.54% | 180.72% | 155.38% | 211.26% | 206.98% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -95.54% | -97.76% | -40.10% | -40.18% | -36.71% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -65.17% | -77.64% | 120.53% | 120.53% | 79.26% |
| Cash from Financing | -33.72% | -65.59% | 15.31% | 15.63% | 4.36% |
| Foreign Exchange rate Adjustments | -618.82% | -51.37% | 742.56% | 414.75% | 191.34% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -29.91% | -78.35% | 549.05% | 566.73% | 465.37% |